360 related articles for article (PubMed ID: 30205359)
1. Resident brain neural precursor cells develop age-dependent loss of therapeutic functions in Alzheimer's mice.
Fainstein N; Dan-Goor N; Ben-Hur T
Neurobiol Aging; 2018 Dec; 72():40-52. PubMed ID: 30205359
[TBL] [Abstract][Full Text] [Related]
2. Failure of Alzheimer's Mice Brain Resident Neural Precursor Cells in Supporting Microglia-Mediated Amyloid β Clearance.
Lachish M; Fainstein N; Ganz T; Sofer L; Ben-Hur T
Cells; 2022 Mar; 11(5):. PubMed ID: 35269501
[TBL] [Abstract][Full Text] [Related]
3. Characterization of age- and stage-dependent impaired adult subventricular neurogenesis in 5XFAD mouse model of Alzheimer's disease.
Park HH; Kim BH; Leem SH; Park YH; Hoe HS; Nam Y; Kim S; Shin SJ; Moon M
BMB Rep; 2023 Sep; 56(9):520-525. PubMed ID: 37482752
[TBL] [Abstract][Full Text] [Related]
4. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
5. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
Dinkins MB; Enasko J; Hernandez C; Wang G; Kong J; Helwa I; Liu Y; Terry AV; Bieberich E
J Neurosci; 2016 Aug; 36(33):8653-67. PubMed ID: 27535912
[TBL] [Abstract][Full Text] [Related]
6. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
7. Brain environment and Alzheimer's disease mutations affect the survival, migration and differentiation of neural progenitor cells.
Karkkainen V; Magga J; Koistinaho J; Malm T
Curr Alzheimer Res; 2012 Nov; 9(9):1030-42. PubMed ID: 22950909
[TBL] [Abstract][Full Text] [Related]
8. Early Impairments of Hippocampal Neurogenesis in 5xFAD Mouse Model of Alzheimer's Disease Are Associated with Altered Expression of SOXB Transcription Factors.
Zaletel I; Schwirtlich M; Perović M; Jovanović M; Stevanović M; Kanazir S; Puškaš N
J Alzheimers Dis; 2018; 65(3):963-976. PubMed ID: 30103323
[TBL] [Abstract][Full Text] [Related]
9. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
10. Can MRI T
Spencer NG; Lovell DP; Elderfield K; Austen B; Howe FA
MAGMA; 2017 Apr; 30(2):153-163. PubMed ID: 27785640
[TBL] [Abstract][Full Text] [Related]
11. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
12. Brain self-protection: the role of endogenous neural progenitor cells in adult brain after cerebral cortical ischemia.
Li B; Piao CS; Liu XY; Guo WP; Xue YQ; Duan WM; Gonzalez-Toledo ME; Zhao LR
Brain Res; 2010 Apr; 1327():91-102. PubMed ID: 20171958
[TBL] [Abstract][Full Text] [Related]
13. MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.
Jeong YO; Shin SJ; Park JY; Ku BK; Song JS; Kim JJ; Jeon SG; Lee SM; Moon M
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29912176
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of Alzheimer's brain pathology in 5XFAD mice by PTH
Chen L; Xiong L; Yao L; Pan J; Arzola E; Zhu X; Mei L; Xiong WC
Alzheimers Res Ther; 2023 Mar; 15(1):53. PubMed ID: 36918976
[TBL] [Abstract][Full Text] [Related]
15. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
[TBL] [Abstract][Full Text] [Related]
16. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of the β-secretase inhibitor GRL-8234 in 5XFAD Alzheimer's transgenic mice lessen during disease progression.
Devi L; Tang J; Ohno M
Curr Alzheimer Res; 2015; 12(1):13-21. PubMed ID: 25523425
[TBL] [Abstract][Full Text] [Related]
18. HuCNS-SC Human NSCs Fail to Differentiate, Form Ectopic Clusters, and Provide No Cognitive Benefits in a Transgenic Model of Alzheimer's Disease.
Marsh SE; Yeung ST; Torres M; Lau L; Davis JL; Monuki ES; Poon WW; Blurton-Jones M
Stem Cell Reports; 2017 Feb; 8(2):235-248. PubMed ID: 28199828
[TBL] [Abstract][Full Text] [Related]
19. Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer's amyloidosis.
Maiti P; Bowers Z; Bourcier-Schultz A; Morse J; Dunbar GL
Alzheimers Res Ther; 2021 Feb; 13(1):37. PubMed ID: 33557949
[TBL] [Abstract][Full Text] [Related]
20. Humoral response in experimental autoimmune encephalomyelitis targets neural precursor cells in the central nervous system of naive rodents.
Kesidou E; Touloumi O; Lagoudaki R; Nousiopoulou E; Theotokis P; Poulatsidou KN; Boziki M; Kofidou E; Delivanoglou N; Minti F; Hadjigeorgiou G; Grigoriadis N; Simeonidou C
J Neuroinflammation; 2017 Nov; 14(1):227. PubMed ID: 29162133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
